SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001563228-18-000014
Filing Date
2018-08-17
Accepted
2018-08-17 13:28:49
Documents
5
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q - 03/31/17 - EASTLAND BIOTECHNOLOGY CORP. f10q_03.31.17_eastgatebiotec.htm 10-Q 262204
2 EXHIBIT 31.1 exhibit31.1.htm EX-31 6424
3 EXHIBIT 31.2 exhibit31.2.htm EX-31 6531
4 EXHIBIT 32.1 exhibit32.1.htm EX-32 3323
5 EXHIBIT 32.2 exhibit32.2.htm EX-32 3530
  Complete submission text file 0001563228-18-000014.txt   283111
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

IRS No.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52886 | Film No.: 181025362
SIC: 6799 Investors, NEC
Office of Real Estate & Construction